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Abstract. 
 
Heat shock protein 90 (Hsp90), an abundant 
molecular chaperone in the eukaryotic cytosol, is in-
volved in the folding of a set of cell regulatory proteins 
and in the re-folding of stress-denatured polypeptides. 
The basic mechanism of action of Hsp90 is not yet un-
derstood. In particular, it has been debated whether 
Hsp90 function is ATP dependent. A recent crystal 
 
structure of the NH
 
2
 
-terminal domain of yeast Hsp90 
established the presence of a conserved nucleotide 
binding site that is identical with the binding site of 
geldanamycin, a specific inhibitor of Hsp90. The func-
tional significance of nucleotide binding by Hsp90 has 
remained unclear. Here we present evidence for a slow 
but clearly detectable ATPase activity in purified 
Hsp90. Based on a new crystal structure of the NH
 
2
 
-ter-
minal domain of human Hsp90 with bound ADP-Mg 
and on the structural homology of this domain with the 
ATPase domain of 
 
Escherichia coli
 
 DNA gyrase, the 
residues of Hsp90 critical in ATP binding (D93) and 
ATP hydrolysis (E47) were identified. The correspond-
ing mutations were made in the yeast Hsp90 homo-
logue, Hsp82, and tested for their ability to functionally 
replace wild-type Hsp82. Our results show that both 
ATP binding and hydrolysis are required for Hsp82 
function in vivo. The mutant Hsp90 proteins tested are 
defective in the binding and ATP hydrolysisÐdepen-
dent cycling of the co-chaperone p23, which is thought 
to regulate the binding and release of substrate 
polypeptide from Hsp90. Remarkably, the complete 
Hsp90 protein is required for ATPase activity and for 
the interaction with p23, suggesting an intricate allo-
steric communication between the domains of the 
Hsp90 dimer. Our results establish Hsp90 as an ATP-
dependent chaperone.
Key words: heat shock protein 90 ¥ molecular chaper-
one ¥ p23 ¥ nucleotide binding ¥ geldanamycin
 
M
 
any
 
 newly synthesized polypeptides depend on
the assistance of molecular chaperones for their
efficient folding. The mechanisms in assisted
protein folding of two main classes of molecular chaper-
ones, the Hsp70s and the chaperonins, have been well
characterized (Gething and Sambrook, 1992; Craig, 1993;
Hartl, 1996; Johnson and Craig, 1997). In contrast, much
less is known about the biochemical mechanism of the
heat shock protein 90 (Hsp90)
 
1
 
 family, another class of
abundant chaperones and constitutively expressed stress
proteins whose members have been highly conserved from
prokaryotes to eukaryotes (Lindquist and Craig, 1988;
Buchner, 1996). The first partial crystal structures of Hsp90
have been published only recently (Prodromou et al.,
1997
 
a
 
,
 
b
 
; Stebbins et al., 1997).
The cellular function of Hsp90 extends beyond the gen-
eral chaperone properties of this protein. Hsp90 is specifi-
cally involved in the folding and conformational regula-
tion of a number of medically relevant signal transduction
molecules, including the nuclear receptors for steroid hor-
mones and several protooncogenic kinases (Smith, 1993;
Nathan and Lindquist, 1995; Frydman and Hhfeld, 1997;
Nathan et al., 1997; Pratt and Toft, 1997). Inhibition of
Hsp90 function by the ansamycin antibiotics (geldanamy-
cin [GA], herbimycin A, macbecin) causes the misfolding
and degradation of these substrates (Whitesell et al., 1994;
Smith et al., 1995; Schneider et al., 1996; Dittmar and
Pratt, 1997). In addition, Hsp90 participates in the renatur-
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ation of some proteins that have unfolded under condi-
tions of cellular stress (Schneider et al., 1996; Nathan et al.,
1997). Although purified Hsp90 can prevent the aggrega-
tion of unfolded proteins and in a minimal system in vitro
cooperates with Hsp70/Hsp40 in the ATP-dependent re-
folding of model proteins (Wiech et al., 1992; Jakob et al.,
1995; Freeman and Morimoto, 1996; Schumacher et al.,
1996; Young et al., 1997; Scheibel et al., 1998), it is likely
that Hsp90 fulfills most of its cellular roles in close co-
operation with a host of cofactors and cochaperones, in-
cluding Hop (p60/Sti1p), the immunophilins FKBP52 and
FKBP51/54, cyclophilin 40 (Cyp40), cdc37 (p50), and p23,
as well as Hsp70 and its cofactors Hsp40, Hip (p48), and
Bag1 (Rap46) (Nair et al., 1996; Frydman and Hhfeld,
1997; Pratt and Toft, 1997; Hhfeld, 1998). Models for the
ordered, yet dynamic interaction of Hsp90 with these co-
factors during the folding of steroid receptors have been
proposed on the basis of experiments in crude cytosol
extracts and partially purified systems (for reviews see
Smith, 1993; Pratt and Toft, 1997). It is generally thought
that an unfolded polypeptide substrate associates first with
the Hsp70 system (Òearly complexÓ) (Smith, 1993) and is
then targeted to Hsp90 via Hop, a tetratricopeptide repeat
(TPR) protein that interacts with both Hsp70 and Hsp90
(Chen et al., 1996; Dittmar et al., 1996; Dittmar and Pratt,
1997; Johnson et al., 1998). This interaction gives rise to
the formation of an Òintermediate complex,Ó containing
Hip, Hop, and Hsp70 in addition to Hsp90. Further re-
modelling results in the Òmature complex,Ó consisting of
Hsp90, p23, an immunophilin, or Cyp40.
 
 
 
The steroid re-
ceptor in this complex is largely folded and competent to
bind hormone with high affinity. The acquisition of this
high affinity conformation is dependent on the interaction
of Hsp90 with the acidic protein p23. Geldanamycin (GA)
prevents p23 binding to Hsp90 and inhibits the proper
folding of steroid receptor (Johnson et al., 1994; Johnson
and Toft, 1995; Smith et al., 1995; Grenert et al., 1997; Sul-
livan et al., 1997).
The mature Hsp90 multi-chaperone complex dissociates
with a 
 
t
 
1/2
 
 of 
 
z
 
5 min and unliganded steroid receptor re-
enters the reaction cycle at the level of the early Hsp70
complex (Smith, 1998). These dynamic interactions are
ATP dependent and thought to be driven by the Hsp70
ATPase. Whether Hsp90 itself binds and hydrolyzes ATP
has been one of the most controversial issues in the chap-
erone literature (Csermely and Kahn, 1991; Wiech et al.,
1992; Csermely et al., 1993; Johnson and Toft, 1994, 1995;
Jakob et al., 1996; Grenert et al., 1997; Scheibel et al.,
1997, 1998). The recent crystal structures of the NH
 
2
 
-ter-
minal 25-kD domain of human and yeast Hsp90 revealed
that this domain binds not only the ansamycin antibiotic
GA but also, in the same site, adenine nucleotide, thus
suggesting that GA acts by inhibiting an ATP-dependent
function of Hsp90 (Prodromou et al., 1997
 
a
 
; Stebbins et al.,
1997). Interestingly, the NH
 
2
 
-terminal domain functions
also in binding unfolded polypeptide
 
 
 
(Young et al., 1997;
Scheibel et al., 1998), either independently or in conjunc-
tion with the COOH-terminal 12-kD domain, which medi-
ates Hsp90 dimerization and the binding of the TPR pro-
teins Hop, FKBP52, FKBP51/54, and Cyp40 (Young et al.,
1998). The NH
 
2
 
- and COOH-terminal domains are con-
nected by a 
 
z
 
35-kD segment of unknown function.
Despite the structural evidence for nucleotide binding
to yeast Hsp90, the putative ATPase function of Hsp90
has remained elusive. Here we present the crystal struc-
ture of the NH
 
2
 
-terminal domain of human Hsp90 with
bound ADP-Mg and demonstrate that Hsp90 indeed has
ATP hydrolytic activity. Based on the crystal structure,
Hsp90 mutants were made that are defective in ATP bind-
ing and ATP hydrolysis. The mutant proteins are unable
to cycle the cofactor p23 and fail to replace wild-type
Hsp90 in yeast in vivo. Thus, Hsp90 is unequivocally iden-
tified as an ATP-dependent molecular chaperone.
 
Materials and Methods
 
Crystallization and X-Ray Analysis
 
The NH
 
2
 
-terminal domain of human Hsp90 (residues 9Ð236) was ex-
pressed and purified as described (Stebbins et al., 1997). Crystals were
grown in the presence of 10 mM adenosine-5
 
9
 
-
 
O
 
-(3-thiotriphosphate)
(ATP
 
g
 
S) and 0.2 M magnesium chloride, from a buffer of 0.1 M Tris-HCl,
pH 8.5, and 30% PEG4000. Data collection, structure determination, and
refinement followed the procedures described for the analysis of the same
domain with bound geldanamycin (Stebbins et al., 1997).
 
Cloning Procedures and Site-directed Mutagenesis
 
Human Hsp90
 
a
 
 cDNA in pUC19 (Aligue et al., 1994) and yeast Hsp82 in
pTGPD/P82 were used as templates for PCR amplification. The coding re-
gion for the yeast homologue of p23 (YKL117W) (Bohen, 1998; Fang et al.,
1998) was amplified by PCR from wild-type yeast genomic DNA. In the
case of Hsp82, PCR products were subcloned into derivatives of the
pET23a Vector (Novagen, Inc., Madison, WI), to generate the recombi-
nant protein fragments containing either a COOH-terminal His
 
6
 
 sequence
followed by an EEF immunotag or an NH
 
2
 
-terminal T7 tag. The cDNAs
encoding human Hsp90 and Hsp90 mutants, as well as human p23 were
cloned into the pAS2-1 vector for the analysis of the Hsp90-p23 interac-
tion in two-hybrid assays (Bartel et al., 1993).
Point mutations in human Hsp90 (E47A, E47D, and D93N) and yeast
Hsp82 (E33A, E33D, and D79N) were generated by PCR amplification
with mismatch oligonucleotides resulting in site-directed exchanges of
codons (Ausubel et al., 1987). The desired exchanges were confirmed by
DNA sequencing. Amplified HSP82 cDNA fragments were subcloned
into the vector pTGPD/P82 for expression in yeast or into pET23a deriva-
tives for expression in 
 
Escherichia coli
 
.
 
Expression of Hsp82 Mutants in Yeast
 
The yeast strain 
 
D
 
PCLDa/
 
a
 
 (Nathan and Lindquist, 1995), used through-
out these experiments, is homozygous for deletion mutations in both
HSP90 genes (HSP82 and HSC82). It is rescued from lethality by the
URA3-containing plasmid pKAT6, which expresses wild-type Hsc82. This
strain was transformed with wild-type and point-mutated Hsp82 in the
expression vector pTGPD/P82 containing the TRP1-marker (Nathan
and Lindquist, 1995). Cotransformants were selected on SD/
 
2
 
Trp/
 
2
 
Ura
plates at 30
 
8
 
C.
To determine the expression levels of Hsp82 constructs, cells were
grown in SD/
 
2
 
Trp/
 
2
 
Ura medium to mid-log phase. Extracts were pre-
pared by agitation of cells with glass beads in ice-cold buffer A (50 mM
potassium phosphate, pH 8.0, 500 mM KCl, 15 mM imidazole, 5 mM
2-mercaptoethanol) supplemented with 1 mM PMSF and protease inhibi-
tor cocktail (Boehringer Mannheim GmbH, Mannheim, Germany). After
centrifugation, Hsp82 proteins were concentrated by incubation of the
supernatants with Ni-NTA. The resin was washed with buffer A and sub-
sequently with buffer B (same as buffer A, but pH 6.0). Finally, the re-
combinant proteins were eluted with 500 mM imidazole in buffer B and
analyzed by SDS-PAGE and immunoblotting with the anti-EEFÐspecific
antibody YL1/2 (Wehland et al., 1984).
To examine the ability of Hsp82 point mutants to support cell viability,
wild-type Hsc82 on the URA3-containing pKAT6 plasmid was replaced
by a HSP82 mutant gene on the TRP1-containing expression vector pT-
GPD/P82 (Sikorski and Boeke, 1991). Cotransformants from the SD/
 
2
 
Trp/
 
2
 
Ura plates were replica plated on 5-FOA (5-fluororotic acid) 
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plates (Sikorski and Boeke, 1991) at 25
 
8
 
C to select for cells that had lost
the original pKAT6 plasmid. After a second round of 5-FOA selection,
loss of the URA3-contaning plasmid pKAT6 was verified by the inability
of these cells to grow on SD/
 
2
 
Ura plates.
 
Interaction of Hsp90 and p23 In Vivo
 
The cDNAs encoding human full-length Hsp90 and mutant derivatives
were inserted in frame into the pAS2-1 vector (CLONTECH Laborato-
ries, Inc., Palo Alto, CA) containing TRP1 as a marker. The different con-
structs were used as a ÒbaitÓ in a two-hybrid assay and were cotrans-
formed into 
 
Saccharomyces cerevisiae
 
 (strain Y190) together with human
p23 in the pACT2 vector (CLONTECH Laboratories, Inc.) carrying a
LEU2 marker. Cotransformants were plated on SD/
 
2
 
Trp/
 
2
 
Leu plates.
The interaction of the bait construct, or the empty pAS2-1 vector as a con-
trol, with the p23 protein was judged by the ability of cotransformants to
grow on SD/
 
2
 
Trp/
 
2
 
Leu/
 
2
 
His plus 25 mM 3-AT (3-amino-1,2,4-triazole)
selection plates.
 
Purification of Recombinant Proteins from E. coli
 
Expression constructs were transformed into 
 
E. coli
 
 BL21(DE3) LysS
cells (Studier et al., 1990). Cells were grown at 18
 
8
 
C in LB medium supple-
mented with 100 mg/l ampicillin and 34 mg/l chloramphenicol to OD
 
600 
 
5
 
1 and protein expression induced for 5 h with 0.25 mM IPTG. After har-
vesting, cell pellets were resuspended and sonicated in buffer A and
Ni-NTA chromatography was performed as described. Proteins were pu-
rified further by ion-exchange chromatography on MonoQ and by gel fil-
tration on Superose 12 (Pharmacia Biotech, Inc., Piscataway, NJ).
Yeast p23 carrying an NH
 
2
 
-terminal T7 immunotag but lacking a His
 
6
 
tag was also expressed in 
 
E. coli 
 
and ammonium sulphate precipitated
from the soluble fraction. After dialysis against buffer Y (10 mM Tris-
HCl, pH 7.5, 50 mM NaCl, 50 mM KCl, 10 mM MgCl
 
2
 
), the protein was
purified further by ion-exchange chromatography on Q-Sepharose Fast
Flow (Pharmacia Biotech, Inc.) in the same buffer and by gel filtration on
Superose 12 in buffer Y.
 
ATP Binding Assay
 
Ni-NTA resin was preblocked with buffer Y containing 5 mM ATP and 2
mM MgCl
 
2
 
. After washing with buffer Y, purified NH
 
2
 
-terminal domains
of wild-type Hsp82 and the E33A and D79N mutants (35 
 
m
 
M each) were
bound to the matrix via their His
 
6
 
 tags by incubation for 15 min at 25
 
8
 
C in
buffer Y
 
 
 
in the presence of 35 
 
m
 
M [
 
a
 
32
 
P]ATP (4 
 
m
 
Ci/mM, Amersham Life
Science, Inc., Arlington Heights, IL). The beads were washed twice with
0.5 ml of buffer Y, protein was eluted with 500 mM imidazole in buffer Y,
and then bound radioactivity was detected by liquid scintillation count-
ing. Specifity of nucleotide binding was demonstrated by competition
with GA.
 
ATPase Assay
 
Recombinant full-length Hsp82 wild-type and mutant proteins (10 
 
m
 
M)
were incubated at 30
 
8
 
C in 40 mM Hepes-KOH, pH 7.4, 2 mM MgCl
 
2 
 
with
0.01Ð0.5 mM [
 
a
 
32
 
P]ATP (4 
 
m
 
Ci/mM, Amersham Life Science, Inc.) for
 
#
 
120 min in a final volume of 20 
 
m
 
l. Reactions were stopped by the addi-
tion of 5 mM EDTA and freezing in liquid nitrogen. Separation of ADP
from ATP was achieved by thin layer chromatography on PEIÐcellulose
sheets (Merck, Darmstadt, Germany) in 0.5 M LiCl and 0.5 M formic acid.
ATPase activity was monitored by quantitation of [
 
a
 
32
 
P]ADP on a Fuji
PhosphorImager (model FLA-2000) using the MacBAS software pack-
age. For specific inhibition of the ATPase activity, GA was added to the
reaction at a final concentration of 180 
 
m
 
M in 1% DMSO. Conrol reac-
tions received DMSO alone.
 
Interaction of Hsp82 and p23 In Vitro
 
Full-length wild-type or mutant Hsp82 proteins (200 
 
m
 
g) were bound to
Ni-NTA resin in buffer Y supplemented with 1% (wt/vol) BSA and 25 mM
imidazole to minimize unspecific protein interactions. Yeast p23 protein
(100 
 
m
 
g) with an NH
 
2
 
-terminal T7 tag was added and the mixture was agi-
tated at 30
 
8
 
C for 45 min in the prescence or absence of nucleotide and
GA. After three washes with buffer Y containing 25 mM imidazole,
Hsp82 protein was eluted from the resin with 500 mM imidazole in the
same buffer, followed by SDS-PAGE, and then immunoblotting with an
antibody against the T7 tag of recombinant yeast p23 (Novagen, Inc.).
 
Miscellaneous Procedures
 
SDS-PAGE was as described (Laemmli et al., 1970). Immunolotting was
performed following the protocol of Towbin et al. (1979). Protein concen-
trations were determined by the BioRad protein assay (BIO RAD Labo-
ratories GmbH, Munchen, Germany). 
 
Results
 
Crystal Structure of the NH
 
2
 
-terminal Domain of 
Human Hsp90 Complexed with ADP-Mg
 
We have previously reported the structure of the NH
 
2
 
-ter-
minal domain of Hsp90 with bound GA (Stebbins et al.,
1997). Here we crystallized the NH
 
2
 
-terminal domain of
human Hsp90 (residues 9Ð236) in the presence of ATP
 
g
 
S.
The crystals formed in spacegroup P2
 
1
 
 with 
 
a
 
 
 
5 
 
53.2 ,
 
b
 
 
 
5 
 
44.1 , 
 
c
 
 
 
5 
 
54.0 , 
 
d 
 
5 
 
115.7¡. Difference fourier
maps showed clear density for ADP and one magnesium
ion consistent with full occupancy, but had no electron
density for a 
 
g
 
-phosphate, either because the 
 
g
 
-phosphate
was disordered or had been lost due to hydrolysis during
crystallization. The structure was refined to 1.5  resolu-
tion with 
 
R
 
cryst
 
/
 
R
 
free
 
 
 
5 
 
17.8/23.5%.
As was observed with the structure of the NH
 
2
 
-terminal
domain of yeast Hsp90 (Prodromou et al., 1997
 
a
 
), ADP-
Mg binds to a site in human Hsp90 where GA also binds
(Stebbins et al., 1997). The contacts between the nucle-
otide and Hsp90 in this complex are very similar to those
observed in the yeast complex (Prodromou et al., 1997
 
a
 
),
and involve both direct and water-mediated hydrogen
bonds (Fig. 1). The N6 group of the adenine purine forms
direct hydrogen bonds with the D93 side chain, and water-
mediated hydrogen bonds with the S52 side chain and L48
backbone carbonyl groups. As in the case of the structure
with bound GA, the interaction with D93 (D79 in yeast
Hsp82) is probably most critical for stable nucleotide bind-
ing. The N7 group of the purine interacts via water-medi-
Figure 1. Structure of the NH2-terminal domain of Hsp90 with
bound ADP-Mg. View into the nucleotide-binding pocket. The
residues D93 and E47, critical for nucleotide binding and hydrol-
ysis, respectively, are colored in yellow. Image was prepared with
the programs MOLSCRIPT (Kraulis, 1991) and RASTER3D
(Merrit and Murphy, 1994). 
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ated hydrogen bonds with the N51 side chain, and the N1
group of the purine with the G97 backbone and D93 and
T81 side chain groups. Additional ADP-Mg contacts in-
clude a hydrogen bond between the O2
 
9
 
 group and the
N106 side chain, a set of hydrogen bonds between the
 
a
 
-phosphate group and the F138, G137 backbone amide
and N51 side chain groups. The Mg ion is octahedrally co-
ordinated by the 
 
a
 
- and 
 
b
 
-phosphate groups of the ADP,
the N51 side chain of Hsp90, and three water molecules.
The conformation of the binding site in the ADP-Mg
complex is essentially identical to the ÒopenÓ conforma-
tion of this site observed in the GAÐHsp90 complex (Steb-
bins et al., 1997), except for the region spanning residues
106Ð124, which differs slightly (0.8Ð1.2  displacements in
C
 
a
 
 positions). As was the case with GA binding, the closed
conformation, which has backbone displacements of as
much as 10 , constricting the opening of the binding
pocket from 12  to 8  (Stebbins et al., 1997), would not
be compatible with ADP-Mg binding. This raises the pos-
sibility that the conformational change is part of a regula-
tory mechanism that may involve nucleotide binding and
turnover.
Interestingly, there is a striking similarity in overall
tertiary structure between the NH
 
2
 
-terminal domain of
Hsp90 and the NH
 
2
 
-terminal ATP-binding domain of the
bacterial type II topoisomerase, DNA gyrase B of 
 
E. coli
 
(Wigley et al., 1991). This similarity extends to the confor-
mation of the bound nucleotide and to most of the criti-
cal interactions between the nucleotide and the binding
pocket. Significantly, a conserved glutamate residue in the
gyrase protein, E42, which corresponds to E47 in the NH
 
2
 
-
terminal domain of human Hsp90 (E33 in the yeast pro-
tein), was identified as the catalytic center for ATP hydrol-
ysis in the gyrase (Jackson and Maxwell, 1993). As shown
in Fig. 1, E47 is indeed positioned such that it could play a
catalytic role in cleaving the 
 
g
 
-phosphate bond of Hsp90-
bound ATP, suggesting that Hsp90 binds and hydrolyzes
ATP in a manner similar to DNA gyrase.
 
Mutations in the ATP Binding Site of Hsp90 Are 
Incompatible with Cell Growth
 
To test the possible functional significance of the con-
served D93 and E47 residues of human Hsp90 for ATP
binding and hydrolysis, respectively, the effects of site-
directed mutations in the corresponding residues D79 and
E33 of yeast Hsp82 (83% similarity and 70% identity with
the human sequence) were analyzed in vivo. Yeast con-
tains two HSP90 genes, HSP82 and HSC82, whose com-
bined deletion is lethal (Borkovich et al., 1989). We there-
fore used a yeast strain (
 
D
 
PCLDa/
 
a
 
) for this analysis that
is deleted in both chromosomal HSP90 genes but rescued
from lethality by constitutive expression of plasmid-encoded
wild-type Hsc82 protein (Nathan and Lindquist, 1995). We
first addressed the question whether mutations of D79 and
E33 affect the expression and gross stability of Hsp82. The
DPCLDa/a strain was cotransformed with an additional
HSP82 gene expressing either wild-type or mutant proteins
(from the same promoter) that could be distinguished
from the preexistent Hsc82 by the presence of COOH-
terminal His6 and EEF tags (Wehland et al., 1984). Yeast
cells expressing either untagged wild-type Hsp82, wild-type
Figure 2. Mutations in the nucleotide-binding site of Hsp90 abol-
ish the function of Hsp90 in vivo. (A) Yeast strain DPCLDa/a
that expresses wild-type Hsc82 from the plasmid pKAT6 (con-
taining the URA3-marker) was cotransformed with wild-type
HSP82 (lane 1), HSP82His6EEF (lane 2), HSP82(E33A)His6EEF
(lane  3), HSP82(E33D)His6EEF (lane 4) and HSP82(D79N)
His6EEF (lane 5). After growth to mid-log phase in liquid SD/
2Trp/2Ura, cell lysates were prepared, adjusted to equal protein
concentrations and His6EEF tagged proteins quantitatively ab-
sorbed with Ni-NTA beads followed by SDS-PAGE and Coo-
massie staining (lanes 1Ð5). Lanes 6Ð10 correspond to lanes 1Ð5
and show an immunoblot with the EEF-specific antibody. Note
that only the band at z90 kD (and two degradation products at
z60 and z50 kD, generated during isolation) are specifically rec-
ognized. (B) The cotransformants described in A were restreaked
on 5-FOA plates at 258C to select for cells that had lost the origi-
nal wild-type plasmid and were rescued from lethality by a func-
tional hsp82 protein. Only wild-type Hsp82, Hsp82His6EEF, and
the E33D mutant were able to support growth.Obermann et al. Hsp90 Function In Vivo 905
Hsp82-His6EEF, or Hsp82-His6EEF proteins containing
the mutations E33A, E33D, or D79N were grown to mid-
log phase. Cell lysates were prepared, adjusted to equal
protein concentrations, and then Hsp82 proteins quantita-
tively adsorbed to Ni-NTA beads via their His6 tags (see
Materials and Methods). All Hsp82-His6EEF proteins
were stably expressed as full-length proteins to very simi-
lar levels (Fig. 2 A), as judged by Coomassie staining and
immunoblotting with anti-EEF antibody. The additional
bands at z50 and z60 kD in the Western blot represent
degradation products of the full-length protein that are
generated during the isolation procedure, as they are not
detected on Western blots of cells that had been solu-
bilized in hot SDS immediately upon harvesting (not
shown). Coexpression of mutant proteins at a level equiva-
lent to that of wild-type Hsp82 was without effect on cell
growth.
To establish whether the mutant forms of Hsp82 were
able to support cell viability in the absence of wild-type
Hsc82, the plasmid shuffling technique (Sikorski and
Boeke, 1991) was used to replace the wild-type HSC82
gene in strain DPCLDa/a with HSP82-His6EEF, mutant
HSP82-His6EEF, or non-tagged wild-type HSP82 as a con-
trol. Cotransformed colonies were selected for growth on
5-FOA plates, indicating the functional replacement of
wild-type HSC82. Surprisingly, only colonies containing
either the wild-type HSP82 gene itself, HSP82-His6EEF,
or HSP82(E33D)-His6EEF were viable (Fig. 2 B). In con-
trast the E33A and the D79N mutants were unable to res-
cue the DPCLDa/a cells from lethality when present as the
only source of Hsp82. These results are consistent with the
view that ATP binding and hydrolysis are critical func-
tional properties of Hsp90 required in vivo.
The rescued cells expressing wild-type Hsp82 and Hsp82-
His6EEF grew with almost identical rates at 308C (dou-
bling time d 5 116 6 2 min and 112 6 5 min, respectively),
indicating that the His6EEF tag does not compromise the
function of Hsp82 in vivo. In contrast, the cells expressing
Hsp82(E33D)-His6EEF grew more slowly (d 5 132 6 1
min) but showed no temperature-sensitive phenotype.
D79 Is Required for ATP Binding and E47 for ATP 
Hydrolysis by Hsp90
To determine the molecular basis for the loss of in vivo
function of the mutant Hsp82 proteins analyzed, we ex-
pressed the full-length proteins and the respective NH2-
terminal domains in soluble form in E. coli and purified
them to homogeneity. Based on the available structural in-
formation, it seemed unlikely that the residue E33 contrib-
utes significantly to ATP or GA binding. Indeed, the NH2-
terminal domain of Hsp82(E33A) bound ATP and GA as
efficiently as the wild-type protein. In contrast, the NH2-
terminal domain of Hsp82(D79N) bound ATP much less
efficiently than wild-type protein (Fig. 3 A), confirming
the prediction from the structural model.
Having analyzed the binding of ATP, experiments were
performed to establish whether Hsp90 has ATP hydrolytic
activity and to test the possible mechanistic significance of
residue E33 in this reaction. Any ATPase activity mea-
sured with Hsp90 has previously been assigned to back-
ground contamination (Scheibel et al., 1997). To avoid
such artifacts, we used only highly purified, recombinant
Hsp90 proteins. Furthermore, we reasoned that an au-
thentic Hsp90 ATPase activity should be inhibited by
GA. ATPase activities were measured with a highly sensi-
tive assay monitoring the production of [a32P]ADP from
[a32P]ATP by thin layer chromatography. ATP hydrolysis
versus time for the various proteins is plotted in Fig. 3 B,
and Fig. 3 C shows the double-reciprocal plot of the data.
Wild-type Hsp82 and Hsp82(E33D) hydrolyzed ATP with
similar kcat values of 0.44 min21 and 0.28 min21, respec-
Figure 3. Mutations in the nucleotide binding site of Hsp90 affect
ATP binding and hydrolysis differentially. (A) Binding of ATP to
the NH2-domains of wild-type and mutant Hsp82 in the presence
and absence of GA (see Materials and Methods). Averages of
three independent experiments are shown with error bars. (B) A
typical plot of ATP hydrolysis versus time at a concentration of
0.05 mM ATP and 10 mM Hsp82. ATPase activity was measured
with [a32P]ATP at 308C as described in Materials and Methods.
The ATPase activity of Hsp82 (closed circles) and the E33D mu-
tant (closed triangles) is specifically inhibited by GA (open circles
and open triangles, respectively). In contrast, the E33A (closed
squares) and D79N mutants (open squares) are devoid of GA-
inhibitable ATPase activity. (C) Double reciprocal plot of the
rate of ATP hydrolysis versus ATP concentration. Km values for
wild-type Hsp82 (closed circles) and for the E33D mutant (closed
triangles) were determined as 172 mM and 520 mM, respectively.The Journal of Cell Biology, Volume 143, 1998 906
tively, which is very similar to the ATPase activity of un-
stimulated mammalian Hsp70 proteins (OÕBrien and
McKay, 1993; Wei and Hendershot, 1995). However, the
Km value of Hsp82(E33D) was about threefold higher
than that of wild-type Hsp82 (520 mM vs. 172 mM), indi-
cating a significantly reduced affinity for nucleotide. Addi-
tion of GA at 180 mM inhibited the ATPase activity al-
most completely. A different result was obtained for the
E33A and D79N mutants. The D79N mutant was devoid
of ATPase activity as expected from its inability to bind
ATP specifically. Significantly, the E33A exchange, al-
though preserving the ability of Hsp90 to bind ATP (Fig. 3
A), abolished the capacity of Hsp90 to hydrolyze ATP.
Thus, E33 in the yeast protein, corresponding to E47 in
human Hsp90, is identified as the catalytic residue of the
Hsp90 ATPase, suggesting a mechanism of ATP hydroly-
sis by Hsp90 similar to that of DNA gyrase (Jackson and
Maxwell, 1993).
The Complete Hsp90 Protein Is Required for
ATPase Activity
Next, we investigated whether the stably folded NH2-ter-
minal domain of Hsp82 (Stebbins et al., 1997; Prodromou
et al., 1997a) is sufficient for the ATPase activity of Hsp82
or whether additional parts of the molecule are required
for ATP hydrolysis. Surprisingly, although the NH2-termi-
nal domain binds ATP (Fig. 3 A), it did not exhibit detect-
able catalytic activity in the ATPase assay (Fig. 4). Simi-
larly, no ATPase activity was detected with a variant of
Hsp82, Hsp82DC (Fig. 4), that lacks the COOH-terminal
dimerization domain (residues 600Ð709; Nemoto et al.,
1995; Wearsch and Nicchitta, 1996), but can be considered
to be native as it was fully soluble after expression in E.
coli and active in prevention of rhodanese aggregation
(Young et al., 1997). Similarly, the NH2-terminal domain
of Hsp82 was properly folded, as it was not only capable of
binding ATP and GA (see Fig. 3 A; Prodromou et al.,
1997a; Stebbins et al., 1997) but also preserved the chaper-
one function in preventing protein aggregation in vitro
(Young et al., 1997; Scheibel et al., 1998; data not shown).
Thus, the complete Hsp90 protein, presumably as the
dimer, is required for ATP hydrolytic activity. Interest-
ingly, the chaperone function of the isolated NH2-terminal
domain did not exhibit a detectable dependence on spe-
cific nucleotide binding (data not shown), suggesting that
ATP hydrolysis may be required for substrate release or
that this function depends on the cooperation of Hsp90
with one or several of its cofactors.
Effect of ATPase Mutations on the Interaction of 
Hsp90 with p23
Recent studies implicated the small acidic protein p23 as
an important cofactor of Hsp90 involved in the maturation
of steroid receptor molecules (Dittmar et al., 1997). Inter-
estingly, Toft and colleagues reported that p23 interacts
with Hsp90 in an ATP-dependent manner (Sullivan et al.,
1997). Initially, it was difficult to reconcile this finding with
the view that Hsp90 neither binds nor hydrolyzes ATP
(Jakob et al., 1996; Scheibel et al., 1997). The recent struc-
tural evidence for ATP binding by Hsp82 (Prodromou et al.,
1997a) together with our demonstration that Hsp90 func-
tion is dependent on ATP binding and hydrolysis in vivo
provided the basis to resolve this issue. Since point muta-
tions mapping within the first 200 residues of Hsp90 abro-
gate the interaction between p23 and Hsp90 (Grenert et al.,
1997), we performed a two-hybrid assay to test whether
the NH2-terminal domain of Hsp90 is sufficient for p23
binding. A set of human Hsp90 constructs (Fig. 5 A) in the
pAS2-1 vector served as the bait and was cotransformed
with human p23 into S. cerevisiae strain Y190. Surpris-
ingly, neither of the Hsp90 deletion fragments was suffi-
cient to interact with p23 (Fig. 5 B), although the frag-
ments were expressed to similar levels as the full-length
Hsp90 protein (Young et al., 1998). Only the full-length
Hsp90 polypeptide was able to interact with p23.
To test whether ATP binding to Hsp90 is required for
the interaction with p23, two-hybrid assays were per-
formed with the respective mutant forms of Hsp90 (Fig. 5
C). Cells containing wild-type Hsp90, Hsp90(E47D), and
Hsp90(E47A) grew in a manner dependent on the interac-
tion between Hsp90 and p23, suggesting that ATP hydrol-
ysis by Hsp90 is not essential for the interaction with p23
measured in vivo. In contrast, no growth was observed
with Hsp90(D93N) in the two-hybrid assay, indicating that
Hsp90 that is defective in nucleotide binding is no more
able to associate with p23. To establish this conclusion
more rigorously, in vitro binding experiments with purified
Hsp82 proteins and yeast p23 (Bohen, 1998; Fang et al.,
1998) were performed. Full-length wild-type and mutant
Hsp82 was purified from E. coli as His6EEF-tagged pro-
teins. Yeast p23 containing an NH2-terminally located T7
immunotag was purified upon expression in E. coli. Wild-
type Hsp82 or Hsp82 proteins carrying the mutations
E33A, E33D or D79N were bound to Ni-NTA resin and
subsequently incubated with p23 (see Materials and Meth-
ods). Binding of p23 to the immobilized Hsp82 was ana-
lyzed by SDS-PAGE and immunoblotting (Fig. 6). Signifi-
cant binding to wild-type Hsp82 and Hsp82(E33D) was
only observed in the presence of the nonhydrolyzable nu-
cleotide ATPgS and was inhibited by GA. In contrast,
Hsp82(E33A) was able to form a complex with p23 in the
presence of hydrolyzable ATP, indicating that p23 inter-
acts with the ATP form of Hsp90. No complex formation
was observed with the D79N mutation of Hsp82, consis-
tent with the lack of detectable nucleotide binding by this
mutant in vitro. These results allow the following conclu-
sions: p23 recognizes the ATP-bound form of Hsp90, but
not the ADP-bound form or the nucleotide-free protein.
As GA inhibits complex formation in the presence of
Figure 4. The complete
Hsp90 protein is required for
ATPase activity. ATP hy-
drolysis versus time at 0.10
mM ATP and 10 mM Hsp82
proteins at 308C is shown for
full-length Hsp82 (FL82,
closed circles), the NH2 do-
main of Hsp82 (N82, closed
triangles) and for DC82, lack-
ing the COOH-terminal resi-
dues 600Ð709 (closed squares).Obermann et al. Hsp90 Function In Vivo 907
ATP, the ansamycin antibiotic mimics the ADP state of
Hsp90, not the ATP state, at least as far as the interaction
with p23 is concerned (see Discussion). In the presence of
ATP, mutant Hsp82 carrying the catalytic site mutation
E33A is arrested in the p23-bound state. In contrast, wild-
type Hsp82 and Hsp82(E33D) are able to cycle between
the p23-bound ATP state and the p23-free ADP and nonÐ
nucleotide-bound states. Given the ATP dependence of
p23 binding it might have been expected that p23 regulates
the ATPase of Hsp90. Surprisingly, however, we failed to
detect any effect of p23 on the ATPase activity of purified
Hsp90 (data not shown).
Discussion
The question whether Hsp90 function is ATP dependent
has been the subject of a long debate. Several groups re-
ported ATP-dependent conformational changes in Hsp90
and ATP-regulated co-factor interactions (Csermely and
Kahn, 1991; Csermely et al., 1993; Johnson and Toft, 1994,
1995; Grenert et al., 1997; Sullivan et al., 1997). On the
other hand, detailed studies in vitro indicated that the
chaperone function of purified Hsp90 is ATP independent
(Wiech et al., 1992; Jakob et al., 1996; Wearsch and Nic-
chitta, 1996; Scheibel et al., 1997), suggesting that the
ATP-regulated aspects of Hsp90 function in protein fold-
ing are due to the close cooperation between Hsp90 and
Hsp70/Hsc70 (Schneider et al., 1996). This view has only
changed recently, based on the crystal structure of the
nucleotide-bound NH2-terminal domain of yeast Hsp90
(Prodromou et al., 1997a), and now human Hsp90 (this
study). However, whether Hsp90 hydrolyzes ATP had re-
mained elusive (Grenert et al., 1997; Prodromou et al.,
1997a; Scheibel et al., 1998). Using the crystal structure of
the NH2-terminal domain as a guide, site-directed muta-
tions were made in Hsp90 that affect ATP binding and hy-
drolysis differentially. By analyzing these mutants in vivo
and in vitro, we now demonstrate not only that Hsp90 has
a clearly detectable ATPase activity, but also that both
ATP binding and hydrolysis are required for Hsp90 func-
tion in vivo. Surprisingly, both the ATPase activity as well
as the interaction of Hsp90 with the cofactor p23 require
Figure 5. Requirement of full-length Hsp90 with an intact ATP-binding site for the interaction with p23 in vivo. (A) Schematic repre-
sentation of the domain structure of human Hsp90 established by limited proteolysis (Stebbins et al., 1997) and of the fragments used in
the two-hybrid assay. (B) Different fragments of Hsp90 in the pAS2-1 bait vector were cotransformed in S. cerevisiae (strain Y190) with
the cDNA encoding human p23 in the pACT2 target vector (see Materials and Methods). To monitor proteinÐprotein interactions,
cotransformants were restreaked on SD/2Trp/2Leu/2His plates containing 25 mM 3-AT and incubated for 5 d at 308C. Cell growth
was only observed with full-length Hsp90 protein but not for any of its subfragments or for the vector control without insert. (C) Full-
length wild-type Hsp90 and the mutants E47A, E47D, and D93N were analyzed for their ability to interact with p23 by two-hybrid assay
as above. Cell growth was observed for wild-type Hsp90, the E47A and E47D mutants, but not for the D93N mutant.
Figure 6. p23 binds the ATP-bound state of purified Hsp90 in
vitro, not the ADP-bound and nucleotide-free forms. Wild-type
and mutant Hsp82 proteins (200 mg each) were bound to Ni-NTA
agarose via their His6 tags and incubated for 45 min at 308C with
yeast p23 (100 mg) and different combinations of nucleotides and
GA as indicated (lanes 2Ð22). In lane 1 (control) Ni-NTA beads
without bound Hsp82 were used. Protein was eluted from the
beads with imidazole and analyzed by 15% SDS-PAGE and im-
munoblotting for the T7 immunotag of p23 (see Materials and
Methods).The Journal of Cell Biology, Volume 143, 1998 908
the complete Hsp90 protein. Furthermore, binding and re-
lease of p23 by Hsp90 follows an ATP hydrolysisÐdepen-
dent reaction cycle. These results show that Hsp90 belongs
to the group of ATP-regulated molecular chaperones.
ATP binding to Hsp90 is inhibited by the ansamycin an-
tibiotic GA that occupies the ATP binding site with high
affinity (Prodromou et al., 1997a; Stebbins et al., 1997), us-
ing essentially the same interactions with the binding
pocket as the purine ring of the nucleotide. Thus, the cel-
lular effects of GA must be interpreted as the conse-
quence of the interruption of the Hsp90 ATPase cycle.
GA blocks the maturation of specific Hsp90 substrates
(for example Whitesell et al., 1994; Smith et al., 1995;
Schneider et al., 1996; Whitesell and Cook, 1996; Dittmar
and Pratt, 1997; Stancato et al., 1997) and the re-folding of
certain stress-denatured polypeptides by the Hsp90 system
(Schneider et al., 1996). Whereas in some cases treatment
with GA has been reported to result in the dissociation of
Hsp90Ðsubstrate complexes (for example Whitesell et al.,
1994), substrate polypeptides often accumulate on GA-
bound Hsp90 in an unfolded conformation that is subject
to degradation by the proteasome system (Smith et al.,
1995; Schneider et al., 1996; Dittmar and Pratt, 1997). This
effect forms the basis for the potential therapeutic applica-
tion of GA derivatives in depleting the cellular levels of
steroid receptors and Hsp90-dependent protooncogenic
protein kinases. The accumulation of substrate polypep-
tide on GA-bound Hsp90 can be explained in light of the
recent finding that Hsp90 contains two distinct sites for the
interaction with substrate polypeptide (Young et al., 1997;
Scheibel et al., 1998), one in the NH2-terminal domain and
one in the COOH-terminal domain. GA binding dissoci-
ates bound polypeptide from the NH2-terminal domain of
Hsp90 but not from the COOH-terminal domain, which
seems to have the general capacity to bind unfolded or
partially folded polypeptides exposing hydrophobic sur-
faces (Young et al., 1997). Similarly, ATP but not ADP
binding has been shown to lower the affinity of the iso-
lated NH2-terminal domain for peptide substrate (Schei-
bel et al., 1998). Since the isolated NH2-terminal domain
does not hydrolyze ATP, it is indeed likely that ATP bind-
ing and not ATP hydrolysis causes the dissociation of
substrate. Those substrates that interact with both the
NH2- and COOH-terminal domains may maintain their
association with Hsp90 in the presence of ATP, whereas
other substrates may dissociate completely from Hsp90
upon ATP binding. It is also possible that nucleotide bind-
ing has an allosteric effect on the COOH-terminal domain,
modulating its polypeptide affinity.
Indeed, the existence of complex, ATP-regulated inter-
actions within the Hsp90 dimer is likely, based on our sur-
prising finding that both the ATPase activity and the in-
teraction of Hsp90 with p23 require the intact Hsp90
molecule. For example, it is conceivable that within the
Hsp90 dimer the NH2-terminal domains may contact each
other, consistent with recent electron microscopic images
of Hsp90 obtained by rotary shadowing (Wearsch and Nic-
chitta, 1996). It is interesting in this context that the sec-
ond domain of DNA gyrase contains a lysine residue
(K337) that interacts with the g-phosphate of the bound
ATP in the ATPase domain, perhaps providing a mecha-
nism for signaling the hydrolysis of ATP to the molecule
as a whole (Wigley et al., 1991). We notice that in our crys-
tal of the ADP-MgÐbound NH2-terminal domain of Hsp90
a lysine residue (K116), coming from a symmetry-related
molecule, points into the area where the g-phosphate
would have been. This conserved residue is near the re-
gion that differs in the open and closed conformations of
the NH2-terminal domain (Stebbins et al., 1997). It is fully
solvent exposed in either conformation and has no obvi-
ous structural role.
Our findings also help to define the ATP hydrolysisÐ
dependent reaction cycle for the binding and release of
p23 by Hsp90. p23 has been described as a component re-
quired for the formation of Hsp90 complexes containing
high ligand affinity steroid aporeceptor (Johnson et al.,
1994; Johnson and Toft, 1995). Before our demonstration
of the ATPase acctivity of Hsp90 it has been reported that
ATP-Mg is required for p23 binding to Hsp90 and that
GA disrupts the Hsp90Ðp23 complex (Johnson and Toft,
1995; Smith et al., 1995; Grenert et al., 1997; Sullivan et al.,
1997). A complete model of the reaction cycle is now
emerging from the analysis of the Hsp90 mutants gener-
ated in this study. Hsp90 defective in hydrolyzing bound
ATP still forms the complex with p23 but is unable to dis-
sociate it. In contrast, the presence of ADP-Mg in the hy-
drolysis-defective protein does not promote p23 binding.
Neither does the nucleotide-free protein associate with
p23. Thus, p23 binds to the ATP-bound form of Hsp90 and
dissociates upon ATP hydrolysis. GA binding mimics the
ADP-bound form of Hsp90 (or the nucleotide-free state)
in that it prevents the interaction of p23 with Hsp90 in the
presence of ATP. In contrast, GA seems to mimic the
ATP-bound form of Hsp90 with regard to substrate bind-
ing to the NH2-terminal domain, consistent with the no-
tion that the binding sites on the NH2-terminal domain for
p23 and substrate are not identical. Notably, the complete
Hsp90 protein, probably as a dimer, is required for p23
binding. Thus, whereas p23 most likely contacts the NH2-
terminal domain directly, its interaction with Hsp90 is
clearly more complex.
In contrast to Hsp90, p23 (Sba1p) is not essential in
yeast but increases the efficiency of expression of heterol-
ogous steroid receptor (Bohen, 1998; Fang et al., 1998).
Thus, the loss of p23 binding to Hsp82(D79N) cannot be
responsible for the lethal phenotype of this mutation.
Rather, ATP binding and hydrolysis by Hsp90 is function-
ally required independently of p23, probably in regulating
substrate binding and release. It is possible, however, that
with the mutant Hsp82(E33A), that is defective in ATP
hydrolysis, trapping of p23 in the Hsp90-bound state may
contribute to the functional defect. The mechanism of p23
action is not yet clear. It is possible that p23 generally in-
creases the efficiency of substrate discharge from Hsp90
by stabilizing the ATP state of the Hsp90 NH2-terminal
domain that has low affinity for polypeptide. Such a func-
tion may be important only for a subset of substrates. Ad-
ditionally, it has been suggested that p23 itself has chaper-
one properties and may interact with the substrate directly
(Bose et al., 1996). Thus, it is also possible that p23 may
function in targeting substrates to Hsp90, similar to the
role of Hsp40 (DnaJ) in targeting substrates to Hsp70
(DnaK) (for review see Hartl, 1996). In contrast to Hsp40,
p23 does not stimulate the ATPase activity of its partnerObermann et al. Hsp90 Function In Vivo 909
chaperone and thus does not generate the ADP-bound
state of Hsp90 that binds to the substrate more stably.
However, such a function may depend on the presence of
substrate polypeptide and may so far have escaped detec-
tion.
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